Prognostic Implications of Chronic Kidney Disease on Patients Presenting with ST-Segment Elevation Myocardial

Gilad Margolis1, Shahar Vig1, Nir Flint1

  • 1Department of Cardiology, Tel Aviv Sourasky Medical Center Affiliated to the Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Cardiorenal Medicine
|June 15, 2017
PubMed

Insights

Chronic kidney disease (CKD) significantly increases long-term mortality risk in ST-segment elevation myocardial infarction (STEMI) patients after percutaneous coronary intervention. Stent thrombosis (ST) did not impact long-term survival in this patient group.

Area of Science:

  • Cardiology
  • Nephrology
  • Clinical Outcomes Research

Background:

  • Limited data exists on long-term outcomes for chronic kidney disease (CKD) patients experiencing stent thrombosis (ST).
  • This study investigates the impact of CKD on long-term mortality in ST-segment elevation myocardial infarction (STEMI) patients treated with primary percutaneous coronary intervention (PCI).
  • The interaction between CKD and ST on mortality was also examined.

Purpose of the Study:

  • To determine the independent effect of CKD on long-term mortality in STEMI patients undergoing primary PCI.
  • To assess whether stent thrombosis (ST) influences long-term mortality in STEMI patients, particularly in the context of CKD.

Main Methods:

  • Retrospective analysis of 1,722 STEMI patients treated with primary PCI.
  • Baseline CKD defined as estimated glomerular filtration rate <60 mL/min/1.73 m².
  • Stent thrombosis (ST) assessed using Academic Research Consortium criteria; long-term mortality was the primary endpoint.

Main Results:

  • 26% of patients had baseline CKD, presenting with more comorbidities and higher ST rates (7% vs 4%).
  • CKD was associated with significantly higher long-term mortality (17.6% vs 2.7%, p < 0.001).
  • CKD independently predicted long-term mortality (HR 2.04, p=0.01), while ST did not significantly affect mortality in either CKD or non-CKD groups.

Conclusions:

  • Chronic kidney disease (CKD) is a significant independent predictor of long-term mortality in STEMI patients treated with primary PCI.
  • Stent thrombosis (ST) does not appear to be a significant predictor of long-term mortality in this population.
Abstract

Related Concept Videos

Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
1.3K
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
338
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
567
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
391
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
266
Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
1.8K